Symbiosis acquires a 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity, financed by £1...
Genentech will acquire Regor's next-generation CDK inhibitors for an upfront payment of $850 million in cash. Regor ...
Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Acceler...
New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapi...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the completion of the acquisition of CN201 from Curon Biopharmaceutical ...
Emmes, part of Emmes Group, announced they will provide a Clinical Coordinating Center for the NIH's National Institute on Drug Abuse Clinical Trials &nbs...
Singular Genomics Systems, a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and cli...
Altamira Therapeutics announces the extension of its exclusive license with Nuance Pharma to cover Singapore, Malaysia, Thailand, Philippines, Indonesia,...
Zydus Lifesciences Ltd., a global innovation driven healthcare company announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE has...
Panacea Biotec, a leading global biopharmaceutical company, is thrilled to announce a new milestone in its mission to protect children from life-threaten...
GeBBS Healthcare Solutions ("GeBBS" or the "Company") specializes in revenue cycle management, health information management (HIM),...
Successful launch of Bentrio by Pharma Nordic AS in Norway in 2024 Exclusive distribution agreement extended to also include Sweden and Denmark Alt...
Emergent BioSolutions Inc. announced it has completed the sale of its drug product facility in Baltimore-Camden to an affiliate of B...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bac...
© 2024 Biopharma Boardroom. All Rights Reserved.
